object
pulmonari
infiltr
allogen
hematopoiet
stem
cell
transplant
allohsct
patient
potenti
lifethreaten
requir
earli
diagnosi
treatment
aim
retrospect
explor
clinic
efficaci
polymeras
chain
reaction
pcr
conjunct
flexibl
bronchoscopi
fb
allohsct
patient
pulmonari
infiltr
patient
method
retrospect
review
patient
undergo
fb
allohsct
peke
univers
institut
hematolog
januari
decemb
use
pcr
detect
variou
virus
fb
specimen
particularli
virus
result
one
hundr
fortynin
diagnost
fb
perform
patient
overal
diagnost
yield
eightynin
percent
patient
posit
fb
result
diagnos
pulmonari
infect
virus
common
infecti
diagnosi
follow
fungi
bacteria
pneumocysti
jirovecii
multivari
analys
show
chest
comput
tomographi
ct
find
diffus
pulmonari
infiltr
p
posit
result
assist
microbiolog
serolog
analys
p
predict
posit
fb
result
fb
result
prompt
treatment
modif
case
conclus
fb
conjunct
pcr
effici
rapid
diagnosi
manag
pulmonari
infiltr
allohsct
patient
k
e
w
r
flexibl
bronchoscopi
hematopoiet
stem
cell
transplant
polymeras
chain
reaction
pulmonari
infiltr
bronchoscopi
perform
respiratori
physician
use
flexibl
fiberopt
bronchoscop
olympu
procedur
perform
nasal
oral
caviti
follow
local
anesthesia
lidocain
support
cardiopulmonari
monitor
continu
assess
puls
rate
blood
pressur
oxygen
satur
fb
sampl
obtain
area
lung
infiltr
multipl
area
present
sampl
obtain
area
infiltr
sever
variou
flexibl
bronchoalveolar
procedur
includ
bronchoalveolar
lavag
bal
protect
sampl
brush
psb
transbronchi
biopsi
tbb
use
establish
diagnosi
decis
request
psb
tbb
made
respiratori
physician
respons
fb
among
patient
underw
multipl
fb
procedur
record
consid
independ
blood
fb
sampl
routin
subject
follow
test
bacteri
pneumonia
defin
presenc
posit
fb
cultur
andor
pcr
strong
clinic
suspicion
lower
respiratori
tract
infect
eg
presenc
fever
cough
purul
sputum
pleurisi
leukocytosi
fungal
pneumonia
defin
posit
fb
cultur
mold
rare
yeast
invas
pulmonari
aspergillosi
ipa
defin
accord
revis
eortcmsg
criteria
polymicrobi
pulmonari
infect
defin
identif
two
infecti
agent
base
criteria
diagnost
yield
fb
consid
proport
case
specif
diagnosi
diffus
alveolar
hemorrhag
dah
defin
bal
sampl
increasingli
bloodi
return
three
separ
sampl
requir
presenc
hemosiderinladen
macrophag
data
censor
time
death
last
avail
followup
continu
variabl
compar
use
mannwhitney
u
test
categor
variabl
compar
use
chisquar
test
fisher
exact
test
kaplanmei
method
use
estim
probabl
os
univari
analysi
perform
use
binari
logist
regress
calcul
odd
ratio
confid
interv
ci
pvalu
multivari
stepwis
logist
regress
analysi
use
assess
relationship
patient
characterist
posit
fb
result
p
consid
statist
signific
attempt
enter
variabl
pvalu
univari
analysi
multivari
analysi
use
logist
regress
pvalu
obtain
use
hypothesi
test
data
analys
conduct
primarili
use
statist
packag
social
scienc
spss
softwar
spss
inc
chicago
il
usa
three
asymptomat
patient
refer
fb
abnorm
discov
incident
upon
ct
patient
n
fever
chest
symptom
cough
sputum
product
dyspnea
pleuriti
time
bronchoscopi
patient
n
neutropen
seven
patient
sever
neutropenia
anc
l
thrombocytopenia
common
median
platelet
count
l
rang
l
one
hundr
nineteen
ct
show
diffus
bilater
infiltr
patient
receiv
empir
antimicrobi
therapi
prior
fb
median
durat
antimicrobi
therapi
fb
day
rang
day
therapi
includ
broadspectrum
antibiot
n
antifung
n
antivir
n
antip
jirovecii
agent
n
thirti
patient
receiv
mechan
ventil
intens
care
unit
fb
univari
analysi
demonstr
nonisd
p
ct
find
diffus
infiltr
p
plt
l
p
posit
assist
microbiolog
serolog
analys
p
statist
margin
associ
higher
likelihood
obtain
posit
fb
result
tabl
overal
treatment
modif
fb
n
firstli
use
pcr
identifi
virus
fb
specimen
evalu
pulmonari
infiltr
allohsct
patient
larg
singlecent
studi
consecut
patient
overal
diagnost
yield
fb
fb
result
prompt
treatment
modif
case
eightynin
percent
posit
fb
result
infect
polymicrobi
etiolog
establish
case
virus
common
infecti
diagnosi
follow
fungi
bacteria
p
jirovecii
attempt
combin
result
bal
psb
tbb
conjunct
pcr
enhanc
diagnost
yield
fb
compar
studi
report
diagnost
yield
howev
present
studi
demonstr
superior
diagnost
yield
sever
explan
may
account
outcom
first
small
size
psb
tbb
strict
definit
bacteri
viral
fungal
pneumonia
could
explain
higher
diagnost
yield
attain
present
studi
despit
use
wide
rang
molecular
diagnost
test
second
patient
receiv
empir
antimicrobi
therapi
prior
fb
potenti
decreas
diagnost
yield
fb
result
correspond
infecti
microorgan
overal
pathogen
consid
relev
mainli
virus
significantli
virus
detect
studi
previou
studi
sever
explan
may
account
outcom
first
bacteri
fungal
infect
primari
caus
infect
neutropen
period
viral
infect
common
midand
laterecoveri
phase
hsct
major
patient
studi
nonneutropen
second
compar
previou
studi
use
pcr
detect
virus
greatli
improv
diagnosi
virus
allow
earli
administr
appropri
therapi
howev
assay
avail
previou
studi
period
result
demonstr
pcr
fast
effect
diagnost
method
virus
studi
cmv
common
pathogen
found
agreement
previou
studi
follow
rsv
parainfluenza
viru
aspergillu
pneumonia
account
fungal
pneumonia
common
copathogen
polymicrobi
pulmonari
infect
group
may
correl
rel
higher
proport
haplohsct
studi
accord
previou
studi
threshold
valu
posit
bal
gm
studi
pjp
found
rel
high
percentag
studi
diagnosi
pjp
confirm
pcr
case
confirm
pcr
rel
sensit
de
incid
dah
observ
consist
incid
report
literatur
fb
result
prompt
treatment
modif
case
higher
report
previous
chang
frequent
identifi
modif
antiinfect
treatment
especi
antivir
treatment
modif
posit
fb
group
significantli
higher
neg
fb
group
signific
differ
mortal
rate
two
group
result
prove
pcr
fb
fast
effect
diagnost
method
identifi
virus
allow
earli
administr
appropri
therapi
therebi
elimin
pathogen
studi
show
diagnost
yield
fb
diffus
infiltr
better
focal
infiltr
consist
find
seneviratna
et
al
lanino
et
al
reason
result
may
diffus
infiltr
greater
probabl
infecti
caus
high
pathogen
burden
focal
infiltr
addit
notabl
differ
studi
compar
previou
report
group
posit
result
assist
microbiolog
serolog
analys
associ
higher
likelihood
obtain
posit
fb
may
also
explain
higher
probabl
infecti
basi
limit
studi
multifactori
first
retrospect
singlecent
studi
second
import
limit
studi
consensu
regard
optim
time
fb
allohsct
recipi
center
may
introduc
bia
third
although
defin
treatment
modif
chang
introduc
within
day
fb
definit
way
ensur
chang
accur
given
retrospect
natur
studi
final
studi
repres
incid
pneumonia
follow
allohsct
would
requir
analysi
allohsct
patient
new
pulmonari
infiltr
summari
larg
singlecent
studi
firstli
use
pcr
identifi
virus
fb
sampl
evalu
pulmonari
infiltr
allohsct
popul
confirm
fb
conjunct
pcr
effici
rapid
diagnosi
manag
pulmonari
infiltr
allohsct
patient
